Legal Representation
Attorney
Shannon Marie McKeon
USPTO Deadlines
Next Deadline
1807 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-07-09)
Due Date
July 09, 2030
Grace Period Ends
January 09, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
32 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Feb 28, 2025 | LIMG | M | LIMITATION OF GOODS RECEIVED FROM IB | Loading... |
| Jan 10, 2025 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Dec 20, 2024 | CORR | I | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | Loading... |
| Dec 20, 2024 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Dec 20, 2024 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Nov 8, 2024 | CRCV | M | CORRECTION TRANSACTION RECEIVED FROM IB | Loading... |
| Oct 9, 2024 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Jul 9, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Jul 9, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 23, 2024 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Apr 23, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 23, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 3, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 3, 2024 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Apr 3, 2024 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Mar 13, 2024 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 13, 2024 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Mar 13, 2024 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 13, 2024 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 13, 2024 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Feb 12, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 12, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 12, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 13, 2023 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Aug 21, 2023 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Aug 21, 2023 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Jul 27, 2023 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Jul 26, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jul 18, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 7, 2023 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Feb 3, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 2, 2023 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals for the treatment and/or prevention of iron deficiency and/or anaemia or of iron overload in humans; veterinary preparations for the treatment and/or prevention of iron deficiency and/or anaemia or of iron overload in animals; dietary supplements for human beings and animals; iron preparations for pharmaceutical use being nutritional supplements; iron preparations for veterinary use being nutritional supplements; iron preparations as dietary supplements; diagnostic preparations for medical and veterinary purposes; molecular weight testing reagents for diagnostic purposes; medicinal, pharmaceutical and veterinary preparations for parenteral administration, in particular oral, intravenous, intramuscular and subcutaneous for the treatment and/or prevention of iron deficiency and/or anaemia or of iron overload in humans; chemical preparations for medical and pharmaceutical purposes, namely, for the treatment and prevention of iron deficiency and/or anaemia or of iron overload in humans; chemical preparations for veterinary purposes, namely, for the treatment and prevention of iron deficiency and/or anaemia or of iron overload in humans
Classification
International Classes
005